Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Full description

Saved in:
Bibliographic Details
Main Authors: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Format: Artigo
Language:Inglês
Published: MDPI AG 2020-10-01
Series:Pharmaceuticals
Subjects:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Online Access:https://www.mdpi.com/1424-8247/13/10/324
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items